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ABSTRACT
The coordinated temporal and spatial activation of
gene expression is essential for proper stem cell
differentiation. The Chromodomain Helicase DNA-
binding protein 1 (CHD1) is a chromatin remodeler
closely associated with transcription and nucleo-
some turnover downstream of the transcriptional
start site (TSS). In this study, we show that CHD1 is
required for the induction of osteoblast-specific gene
expression, extracellular-matrix mineralization and
ectopic bone formation in vivo. Genome-wide occu-
pancy analyses revealed increased CHD1 occupancy
around the TSS of differentiation-activated genes.
Furthermore, we observed that CHD1-dependent
genes are mainly induced during osteoblast differen-
tiation and are characterized by higher levels of CHD1
occupancy around the TSS. Interestingly, CHD1 de-
pletion resulted in increased pausing of RNA Poly-
merase II (RNAPII) and decreased H2A.Z occupancy
close to the TSS, but not at enhancer regions. These
findings reveal a novel role for CHD1 during os-
teoblast differentiation and provide further insights
into the intricacies of epigenetic regulatory mecha-
nisms controlling cell fate determination.
INTRODUCTION
Bone marrow-derived skeletal (also known as stromal or
mesenchymal) stem cells (MSC) are self-renewable andmul-
tipotent adult stem cells residing perivascular in the bone
marrow niche and can differentiate into adipocytes and
osteoblasts (1–4). The differentiation of MSC is directed
by lineage-specific transcription factors and is accompa-
nied by changes within the chromatin around gene promot-
ers and regulatory regions (5–7). These chromatin changes
accompany gene expression regulation and include post-
translational histone modifications, chromatin remodeling
and exchange of histone variants (8). While the importance
of chromatin remodeling for gene induction and mainte-
nance of cell identity is well established, mechanistic and
regulatory insights remain elusive (9). Concordantly, many
proteins which slide, disrupt or replace nucleosomes are piv-
otal for various reprogramming and differentiation events
(10,11). Moreover, during differentiation, the proximal re-
gion surrounding the transcriptional start site (TSS) under-
goes changes in histone modifications and incorporation of
the histone variants H2A.Z andH3.3 (12–15). In particular,
the first nucleosome represents a barrier to the early elon-
gating RNA Polymerase II (RNAPII) and can be modu-
lated by the above mentioned chromatin changes, where its
regulation is particularly important in controlling gene ac-
tivity (16–19).
CHD1 is a highly conserved ATP-dependent chromatin
remodeling protein which is associated with active genes
(10,20) and interacts with transcription-related complexes
such as Polymerase Associated Factor (PAF), Facilitates
Chromatin Transcription (FACT), Mediator and the U2
snRNP splicing complex (21–23). Its binding to chromatin
is enhanced by H3K4me2/3 (22), a histone modification
located predominantly around the TSS, where CHD1 pro-
motes nucleosome turnover and decreases the nucleosomal
barrier toRNAPII (16,24). Concordantly, it was shown that
CHD1 enhances gene activation after stimulation in nor-
mal and tumor cells (20,25) and elevates global transcrip-
tional output in specific cell types (26). Furthermore, CHD1
is not only required for the maintenance of pluripotency in
mouse embryonic stem cells (mESC) but also for efficient
reprogramming as well as differentiation of hematopoietic
stem cell progenitors (10,27). Although these studies clearly
establish the importance of CHD1 for differentiation, its
regulatory role in controlling gene expression changes dur-
ing differentiation and the underlying molecular mecha-
nisms remain unclear. Given the increasing interest in MSC
for regenerative medicine purposes (28) as well as a previ-
ous study reporting that CHD1 is required for maintain-
ing proper levels of histone H2B monoubiquitination (29),
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which we previously demonstrated to be crucial for MSC
differentiation (30), we hypothesized that CHD1 may also
have a role in controlling osteoblast differentiation.
Here, we show that CHD1 is required for transcriptional
changes during osteoblast differentiation of MSC and for
in vivo ectopic bone formation. Genome-wide binding stud-
ies revealed a significant increase in CHD1 occupancy near
the TSS of differentiation-activated genes in osteoblasts as
well as adipocytes. Interestingly, we observed that CHD1-
dependent genes highly overlapped with differentiation-
induced genes, which displayed a particular enrichment of
CHD1 around their TSS. Finally, CHD1 depletion resulted
in defective RNAPII elongation at these genes and a global
increase in RNAPII pausing at the TSS accompanied by de-
creased H2A.Z occupancy near the TSS.
MATERIALS AND METHODS
Cell culture
Human fetal osteoblast (hFOB 1.19) and human skeletal
(mesenchymal) stem cells (hMSC-Tert) were maintained
as previously described (31,32). In brief, MSC were cul-
tured in alpha-Minimum essential medium Eagle modi-
fication (-MEM, Invitrogen) and hFOB 1.19 in phenol
red-free high-glucose Dulbecco’s modified Eagle’s medium
(DMEM/F12, Invitrogen), both supplemented with 10%
fetal bovine serum (Thermo Fisher Scientific) and 1%
penicillin/streptomycin (Sigma-Aldrich). For differentia-
tion confluent cells were treated with a differentiation cock-
tail as described previously (30) every alternative day for 5
days in total. hFOB 1.19 cells were shifted to 39◦C for 2 h
before differentiation.
Generation of stable shRNA expressing cell lines
Individual pGIPZ plasmids encoding microRNA-adapted
short hairpin RNAs (shRNA) which target the mRNA
of CHD1 (shRNA-CHD1 #1––V2LHS 312675; shRNA-
CHD1 #2––V2LHS 112971) or non-targeting (shRNA-
nt––RHS4346) were purchased from OpenBiosystems.
Lentiviral particles were produced by transfection of HEK-
293T cells via linear polyethylenimine (PEI) with pGIPZ,
psPAX2packaging plasmid and pMD2.G envelope plasmid
(Addgene plasmids #12260, #12259). The viral-containing
supernatant was harvested 2 days after transfection and
applied to MSC medium together with 8g/ml polybrene.
Two days after transduction cells were selectedwith 1g/ml
puromycin and maintained in this medium for at least 10
days before performing further experiments.
Ectopic bone formation
Injection of cells, tissue preparation and quantification were
performed as described previously (33). In brief, MSC
cell lines expressing non-targeting (MSC-shRNA #nt) or
CHD1 targeting shRNAs (MSC-shRNA CHD1 #1 and
#2) as well as untransformed MSC were seeded onto a
hydroxyapatite/tricalcium phosphate (HA/TCP, Zimmer
Inc.) matrix and subcutaneously implanted into female 8-
week old NOD.CB17-Prkdc<scid>/J (‘NOD-scid’) mice.
The mice were sacrificed 8 weeks after implantation and the
processed tissue sections were stained by H&E to measure
the formed bone area (BA) relative to the total tissue area
(TA). For statistical analysis, a single-factor ANOVA test
was performed between the control group (MSC untrans-
formed, n = 3; MSC-shRNA-NT, n = 2) and the CHD1-
depleted group (MSC-shRNACHD1 #1, n= 4; andMSC-
shRNA CHD1 #2, n = 4) to analyze statistical differences
among the groups. The groups were further analyzed by
Tukey multiple comparison tests with a significance thresh-
old set to 0.05.
siRNA transfection
siRNA was transfected using Lipofectamine RNAiMAX
(Invitrogen) according to the manufacturer’s instructions.
Control siRNA (Luciferase GL2 duplex; target sequence:
CGUACGCGGAAUACUUCGA), single CHD1 targeting
siRNA (siCHD1 #1––CAUCAAGCCUCAUCUAAUA;
siCHD1 #2––GAAACAAGCUCUAGAUCAU) and a
pool of four CHD1 targeting siRNAs (siCHD1) were pur-
chased from Dharmacon, ThermoScientific. Cells were
transfected 36 h before differentiation and again 48 h after
differentiation.
Western Blot, qRT-PCR, alkaline phosphatase and Alizarin
Red S staining
Isolation of RNA and proteins as well as western blot anal-
ysis, reverse transcription and qRT-PCR were performed
as previously described (30,34). Antibodies and qRT-PCR
primers used in this study are listed in Supplementary Ta-
ble S5. For alkaline phosphatase (AP) staining, the Leuko-
cyte Alkaline Phosphatase Kit (Sigma-Aldrich) was used
according to the manufacturer’s protocol. Alizarin Red S
staining was performed as previously described (35). For
AP and Alizarin Red S quantification the whole wells
were scanned and the stained area was quantified with the
Threshold Color Plugin on ImageJ software relative to the
total measured area. Statistical analysis of qRT-PCR and
stainings were performed with two-tailed two-sample Stu-
dent’s t-test.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed as
described previously (30,34). In brief, cells were fixed in
1% or 1.42% formaldehyde (for CHD1 ChIP) for 10 min.
Nuclear pellets were isolated in nuclear preparation buffer
(150 mM NaCl, 50 mM Tris–HCl (pH 7.5), 5 mM EDTA,
NP-40 (0.5%, v/v), Triton X-100 (1.0%, v/v)), pellets were
washed in the same buffer and then sonicated in lysis buffer
(150 mM NaCl, NP-40 (1%, v/v), sodium deoxycholate
(0.5%, w/v), SDS (0.1%, w/v), 50 mM Tris–HCl (pH 8), 20
mMEDTA, 20 mM sodium fluoride and protease inhibitor
cocktail) for 30 cycles (30 s on/off) using a Bioruptor Pico
(Diagenode). The sheared chromatin was first precleared by
adding lysis buffer supplemented with 50% Sepharose 4B
beads (GE Healthcare) and then incubated separately with
the corresponding antibodies for 16 h (Supplementary Ta-
ble S6). Immunocomplexes were precipitated by Protein-A
or -G sepharose (GE Healthcare) for 2 h and washed there-
after with lysis buffer, wash buffer (100 mM Tris (pH 8.5),
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500 mM LiCl, NP-40 (1%, v/v), sodium deoxycholate (1%,
w/v), 20 mM EDTA, 20 mM NaF) and finally twice with
TE buffer. Samples were treated with RNase A (Qiagen)
and incubated with 20 mM EDTA, 100 mM Tris–HCl (pH
8), SDS (2%, w/v) and 20 g Proteinase K for 16 h at 65◦C.
The DNA was isolated via phenol–chloroform extraction
and used for qRT-PCR or ChIP-seq analysis.
Formaldehyde-assisted isolation of regulatory elements
The Formaldehyde-Assisted Isolation of Regulatory Ele-
ments (FAIRE) protocol was performed as previously de-
scribed with modifications in the isolation step of cell nu-
clei (36). Briefly, cells were crosslinked for 10 min with 1%
formaldehyde at room temperature and cell nuclei were iso-
lated as for ChIP. Samples were then sheared for 10 cycles
(30 s on/off) in Bioruptor Pico Microtubes (Diagenode).
DNA and RNA library preparation
DNA libraries for sequencing were prepared using the Mi-
croPlex Library Preparation Kit v2 (Diagenode) according
to the manufacturer’s protocol. Prior to library preparation
the DNA was sheared for another 30 cycles (30 s on/off)
to ensure optimal fragment size for sequencing. For CHD1
ChIP the NEBNext Ultra DNA Library Prep Kit (NEB)
was used. Before RNA-seq library preparation RNA in-
tegrity was confirmed using a Bioanalyzer 2100 (Agilent)
andmRNAwas purified from 1g total RNAvia theNEB-
Next Poly(A) mRNA Magnetic Isolation Module (NEB)
before proceeding with the NEBNext Ultra RNA Library
Prep Kit for Illumina (NEB). Before sequencing DNA size
was measured and found to be ca. 300 bp using the Bio-
analyzer 2100 (Agilent). Single-end 50 bp sequencing was
performed on an Illumina HiSeq2500.
RNA-seq bioinformatic analysis
RNA-seq data processing was performed as described pre-
viously (34). Reads were mapped to the human reference
transcriptome (UCSC hg19) using Bowtie2 (version 2.1.0)
(37). Read counts for samples and genes were aggregated
using a custom Ruby script and differential gene expres-
sion was analyzed byDEseq (version 1.14.0) (38) in R 3.1.0.
Significantly differentially regulated genes were selected by
a Benjamini–Hochberg adjusted P-value below 0.05 and
log2-fold change values above 0.5 or below –0.5 for up- and
downregulated genes, respectively. Heatmaps were created
with heatmap.2 from gplots R package (39). Grouping of
gene expression into quintiles was done on all expressed
genes having a basemean value>10. Experiments were per-
formed in biological duplicates. The similarities between
replicates were assessed via principle component analysis
(PCA). The PCA plot was calculated and plotted based on
the software package DESeq (38).
DAVID analysis
Gene ontology (GO) analysis was performed using the
Database forAnnotation, Visualization and IntegratedDis-
covery (DAVID) tool (version 6.7) with default conditions
(40) using gene identifiers (IDs) and Homo sapiens set as
background. The top two enriched annotation clusters and
selected terms were listed as indicated.
ChIP-seq bioinformatic analysis
Readsweremapped to the human reference genome (UCSC
GRCh37/hg19) using Bowtie (version 1.1.1) with parame-
ters set to -m 1 and -k 1 (41) and converted to BAM for-
mat via samtools (version 1.2) (42). BAM files were fur-
ther processed using the BamCoverage tool within the deep-
tools2 software (43) and normalized to reads per genomic
content (RPGC). All experiments were performed in bi-
ological triplicates except H3.3 ChIP-seq, which was per-
formed in duplicates for siCHD1 and a single replicate
for control siRNA transfected hFOB 1.19. For peak call-
ing Model-based Analysis of ChIP-Seq (MACS2) (version
2.1.0) was used with input samples set as background and
default parameters (q-value < 0.05) (44). Genomic local-
ization of CHD1 peaks (MSC-Ob, n = 8853; K562, n =
59924) relative to annotation was analyzed using the cis-
regulatory Element Annotation System (CEAS) software
(version 1.0.2) with default parameters (45). Single gene
profiles were visualized in the Integrated Genome Viewer
(IGV; version 2.3.14) (46). Heatmaps, aggregate and corre-
lation plots were created with the deeptools2 software. For
correlation plots the regions from the TSS to 1 kb down-
stream were used. For illustrating average profiles over all
genes the computeMatrix scale region mode was used by
averaging genes to 60 kb with 10 kb up- and downstream of
the TSS and TES, respectively. Gene coordinates as well as
CpG-island information were downloaded from the UCSC
Table Browser (UCSC genes GRCh37/hg19) (47). Genes
with multiple TSS were selected for the TSS with high-
est CHD1 occupancy. For this purpose, occupancy values
were calculated within a region from TSS to +1 kb us-
ing the computeMatrix tool. Differential binding analy-
sis of ChIP-Seq peak data was performed for all CHD1
called peak regions identified with MACS2 in undifferen-
tiated and osteoblast-differentiated conditions using Diff-
Bind (version 1.10.2) (48). Significantly enriched regions in
the osteoblast-differentiated condition (P-value < 0.05 and
False Discovery Rate < 0.1) were used as an input for the
Genomic Regions Enrichment Annotation Tool (GREAT)
(49) with the setting ‘single nearest gene’.
Bivalent promoter regions were defined by overlapping
H3K4me3- andH3K27me3-enriched regions in undifferen-
tiated MSC identified by MACS2 with default parameters.
Further, these regions were overlapped with TSS expanded
in each direction for 1 kb. hFOB 1.19-specific enhancer re-
gions were defined as recently described (35). Briefly, seg-
ments enriched for H3K4me1, H3K27ac and BRD4, but
depleted for H3K27me3 or H3K4me3, were specified as en-
hancer sites (n = 5409 regions). Averaged ChIP-seq signals
at these regions were calculated by scale-region mode over
computeMatrix. Analysis of additional transcription factor
binding was further performed using the ReMap tool (50).
RNAPII pausing ratio
The RNAPII pausing ratio was calculated as described pre-
viously (51). Briefly, the TSS region was defined as a win-
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dow ranging from 300 bp upstream of the TSS to 30% of
gene body length added downstream to the TSS. The gene
body (GB) was set as 30% of gene body length downstream
of TSS to 3 kb downstream of TES. Genes smaller than 600
bp were excluded from analysis to reduce bias between the
signal of TSS and GB (52). The RNAPII occupancy was
measured as the median value over the GB and as the mean
value at TSS using the computeMatrix tool in deeptools2
via scaleRegion mode. Genes were considered for calcula-
tion of the RNAPII pausing ratio if the RNAPII signal was
over 1.4 RPGC at the TSS and a median value at the gene
body above 0.1 RPGC. In total, the pausing ratio was calcu-
lated for 11,502 genes. For statistical analysis pausing ratios
were compared by Wilcoxon-rank sum test.
Publically available datasets
SRAdata ofDNaseI hypersensitivity (GEO:GSM1946442,
GSM1946441) (7), H3K27ac in differentiated, RNA Poly-
merase II in undifferentiated and differentiated hFOB 1.19
(35) were processed as described above and used as indi-
cated.
RESULTS
CHD1 is required for transcriptional programming during os-
teoblast differentiation
To elucidate the role of CHD1 in lineage specification
we utilized the well-established MSC model of differenti-
ation into the osteoblast lineage. Interestingly, depletion of
CHD1 (Supplementary Figure S1A) during osteoblast dif-
ferentiation of MSC led to increased alkaline phosphatase
(AP) activity (Figure 1A) and mRNA levels (ALPL; Fig-
ure 1B). Furthermore, the expression of two other early
osteoblast-specific genes BGLAP and RUNX2 were simi-
larly increased upon CHD1 depletion. In contrast, other
genes activated during osteoblastdifferentiation such as
DKK1, ELN and CTGF displayed decreased expression
levels following CHD1 depletion (Figure 1C). This ini-
tially suggested a gene-specific role of CHD1 in regulat-
ing transcription during osteoblast differentiation. There-
fore, in order to further determine the extent of the effects
of CHD1 depletion on genes regulated during osteoblast
differentiation we performed transcriptome-wide mRNA
sequencing analyses in MSC and human fetal osteoblasts
(hFOB 1.19) (Figure 1D, Supplementary Figure S1C). In
total, 1416 genes in MSC and 4749 genes in hFOB 1.19
were induced during osteoblast differentiation while 1292
and 4844 genes were repressed in MSC and hFOB 1.19,
respectively. Notably, CHD1 depletion largely attenuated
gene expression changes induced by differentiation (Fig-
ure 1C), as 550 differentiation-activated genes in MSC and
419 in hFOB 1.19 were less activated upon CHD1 deple-
tion while 452 and 341 genes were more weakly repressed
in MSC and hFOB 1.19, respectively (Supplementary Fig-
ure S1B). To further investigate the transcriptional changes
of CHD1-regulated genes during differentiation we ana-
lyzed their gene expression and correlation between un-
differentiated and osteoblast-differentiated states in con-
trol and CHD1-depleted conditions. Consistent with de-
creased mRNA levels upon CHD1-depletion, a higher cor-
relation was observed between the gene expression patterns
of undifferentiated cells to the CHD1-depleted osteoblast-
differentiated condition compared to control osteoblast-
differentiated condition (Supplementary Figure S1D). This
supports the idea that CHD1 is required for transcriptional
changes during osteogenesis and that loss of CHD1 main-
tains cells in a more undifferentiated state even in the pres-
ence of differentiation-inducing signals. Additionally, prin-
ciple component analysis (PCA) revealed considerable dif-
ferences between the various conditions (differentiation and
with CHD1 depletion) at the transcriptome level, as well
as good concordance between single replicates (Supplemen-
tary Figure S1D). Next, we performed gene ontology (GO)
analyses of the CHD1-regulated genes in MSC and hFOB
1.19. This revealed an enrichment of genes associated with
skeletal system development, developmental processes, re-
sponse to stimuli and the extracellular matrix, which is
strongly remodeled during osteogenesis and required for os-
teoblast differentiation (53) (Supplementary Table S1).
In order to examine the effect of CHD1 depletion on
bone formation in vivo, two stable CHD1-shRNA and one
non-targeting shRNA-expressing MSC cell lines were es-
tablished and tested for their ectopic bone formation capac-
ity in immune-deficient mice (Supplementary Figure S2A).
Interestingly, both CHD1-depleted MSC cell lines formed
significantly less bone tissue compared to control cells and
showed less extracellular matrix (Figure 1E and F). As we
observed defects in expression of extracellular matrix genes
and decreased bone formation we investigated if mineral-
ization, a later step in osteoblast differentiation, and de-
pendent on the extracellular matrix, was also impaired.
Indeed, as assessed by Alizarin Red S staining, CHD1-
deficient MSC displayed less mineralization capacity (Fig-
ure 1G). Consistent with these findings, phenotype char-
acterization data from the International Mouse Phenotype
Consortium (54) revealed that heterozygous Chd1 knock-
out mice have lower bone mineral density and bone mineral
content compared to wildtype mice (Supplementary Fig-
ure S2B). Together, these observations imply that CHD1 is
required for osteogenesis by regulating the transcriptional
program specifically at later stages of osteoblast differenti-
ation.
Notably, the function of CHD1 in regulating
differentiation-induced gene expression was not lim-
ited to the osteoblast lineage. CHD1 depletion also resulted
in reduced induction of lineage-specific genes during
adipocyte differentiation (Supplementary Figure S3A),
suggesting a more general function of CHD1 in regulating
differentiation-related transcriptional programs in MSC.
CHD1 occupancy increases near the TSS of differentiation-
induced genes
To understand the molecular mechanisms by which CHD1
functions during MSC differentiation, we studied its
genome-wide occupancy during both adipogenesis and os-
teogenesis by chromatin immunoprecipitation followed by
high throughput sequencing (ChIP-seq). Consistent with
a function in controlling gene expression, most CHD1-
enriched regions were located within genes, with the high-
est abundance in introns and promoter regions (Figure 2A).
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Figure 1. CHD1 depletion impairs osteoblast differentiation in MSC and hFOB 1.19. (A) Osteoblast-differentiated mesenchymal stem cells (Ob. diff)
transfected with control (siCon) or CHD1 (siCHD1) siRNAs were stained for alkaline phosphatase (AP) activity. Mean values ± SD (n = 2), with P-
value shown. qRT-PCR gene expression analysis of CHD1 and the osteoblast-specific genes ALPL, BGLAP, RUNX2 (B) and DKK1, ELN, CTGF (C)
in undifferentiated (Undiff.) and osteoblast-differentiated (Ob. diff) mesenchymal stem cells transfected with control (siCon) or CHD1 targeting siRNA
(siCHD1). Values were normalized to 18S rRNA and quantified relative to control undifferentiated samples. Mean ± SD, (n = 3) (*P-value < 0.05; **P-
value < 0.01; ***P-value < 0.001). (D) Heatmaps depict log2-fold changes of gene expression in MSC and human fetal osteoblasts (hFOB 1.19) during
osteoblast differentiation. Relative changes upon siCHD1 treatment (Diff. +siCHD1) compared to differentiation-associated changes in gene expression
are shown in the lower panel of each heatmap. Genes were sorted by log2-fold changes with siCHD1 treatment and differentiation-regulated genes were
selected by adjusted P-value < 0.05 and ±0.5 log2-fold changes. (E) Representative H&E stained tissue sections of ectopic bone formation (pink area;
see black arrow) in SCID mice implanted with MSC stably expressing a non-targeting (#nt) or CHD1-targeting shRNAs (#1, #2). Mice were sacrificed
8 weeks after implantation. Scale bars represent 100 M. (F) Boxplots show the quantification of ectopic bone formation of control and CHD1-shRNA
expressing MSC with each point representing one biological replicate. The ratio of bone area (BA) over total area (TA) was compared with Tukey multiple
comparison test with a threshold at 0.05 (*). (G) Representative images of Alizarin Red S staining of MSC differentiated for 14 days in control (#nt) and
CHD1-depleted (CHD1 #1, #2) are shown with the quantification of the relative percentage of stained area over total area (n = 3; * P-value < 0.05).
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Figure 2. CHD1 occupancy increases near the TSS of differentiation-induced genes. (A) Relative genome-wide CHD1 occupancy analysis at regulatory
elements in osteoblast-differentiated MSC (MSC-Ob.) represented by a pie chart with the color code on the right. Analysis was performed via CEAS.
(B, C) Occupancy of H3K27ac, CpG frequency and H3K27me3 relative to CHD1-occupied transcriptional start sites (TSS) ordered from high to low
based on CHD1 occupancy in MSC-Ob. (B) and hFOB 1.19 (C). (D) Aggregate plot of CHD1 around the TSS of osteoblast differentiation-induced
genes in undifferentiated (black) and differentiated (red) conditions. Quantification of CHD1 occupancy at induced (induc.), unregulated (unreg.) or
repressed (repr.) gene groups in undifferentiated (MSC) and differentiated (MSC-Ob) conditions are shown on the right. P-values below 0.05 are shown
unless indicated as not significant (n.s.). (E) Aggregate plot of CHD1 as described in D but for adipocyte differentiation-regulated gene groups (Adi.). (F)
Aggregate plot of CHD1 around the TSS in hFOB 1.19 at genes induced (red), unregulated (green) or repressed (blue) during osteoblast differentiation.
Boxplots on the right show quantitation of CHD1 occupancy with P-values indicated above boxplots. (G) The lists represent significantly enriched gene
ontology (GO) terms at high CHD1-occupied genes around the TSS of osteoblast-differentiation induced genes in MSC-Ob. and hFOB 1.19. GO analysis
was performed with the DAVID analysis tool with the adjusted P-value (Benjamini) and count of genes within the respective term.
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The strongest CHD1 occupancy was observed at the proxi-
mal region downstream of the TSS (Supplementary Figure
S4A). The occupancy of CHD1 generally correlated with
the intensity of the active histone modification H3K27ac
and was co-localized with a higher CpG content near the
TSS, but was not correlated with H3K27me3 in MSC and
hFOB 1.19 (Figure 2B and C). Next, we tested if transcrip-
tional changes occurring during differentiation are also ac-
companied by changes in CHD1 occupancy. Therefore, we
focused on a region between 0 and 1 kb downstream of the
TSS where CHD1 occupancy was highest and where CHD1
was previously shown to facilitate nucleosome turnover
(16). Indeed, CHD1 occupancy significantly increased near
the TSS of osteoblast-activated genes during differentiation
(Figure 2D). Moreover, we observed a significant increase
in CHD1 occupancy at induced genes during osteogenesis
in comparison to genes which were repressed or unregu-
lated during differentiation in MSC (Figure 2D). A simi-
lar pattern was also observed during adipogenesis (Figure
2E), suggesting that CHD1, like H2B monoubiquitination
(30), may generally be required for MSC differentiation-
associated gene expression changes. Together, these findings
demonstrate that CHD1 occupancy near the TSS is strongly
increased and accompanies regulatory changes during dif-
ferentiation. To more precisely characterize the changes in
CHD1occupancy during osteoblast-differentiationwe used
DiffBind to identify differentially-associated regions and
GREAT analysis for the functional categorization of these
regions. Most of the differentially enriched regions were in
close proximity to the TSS, but not intergenic regions (Sup-
plementary Figure S4B). Notably, these genes were signifi-
cantly enriched with genes associated with extracellular ma-
trix components (Supplementary Figure S4C). Since differ-
entiation of stem cells often involves transcriptional regu-
lation of bivalent genes marked with both H3K4me3 and
H3K27me3 (12), we examined whether CHD1 would simi-
larly target these promoters. However, only a small fraction
of bivalent genes which are activated upon osteoblast differ-
entiation were dependent on CHD1 (Supplementary Figure
S4D).
To more precisely characterize the genes regulated dur-
ing osteogenesis in hFOB 1.19 we classified these into two
groups based on high and low CHD1 occupancy (Supple-
mentary Figure S4E). Overall, we observed a significant en-
richment of CHD1 at differentiation-induced genes in the
highly expressed and highly CHD1-occupied fraction, but
not in the lower expressed fraction (Supplementary Figure
S4F, Figure 2F). This difference inCHD1occupancy and its
correlation with the induction of osteoblast-specific genes
prompted us to perform GO analyses on the low and high
occupied groups. The higher CHD1-occupied fraction of
genes showed an enrichment of GO terms associated with
cellular differentiation, developmental processes and the ex-
tracellular region, whichwere not enriched in the low bound
fraction (Figure 2G, Supplementary Table S2). Interest-
ingly, the top 20% of CHD1-enriched and differentiation-
induced genes showed the highest association with cellu-
lar differentiation and skeletal terms compared to the oth-
ers fractions (Supplementary Table S3), indicating that the
highly CHD1-occupied genes are more closely associated
with osteoblast-specific functions. Taken together, these re-
sults show that differentiation-induced genes display an in-
creased recruitment of CHD1 specifically around the TSS
of osteoblast differentiation-related genes.
CHD1-dependent genes display higher CHD1 occupancy
near the TSS
After observing high occupancy of CHD1 near the TSS of
differentiation-induced genes and its requirement for tran-
scriptional changes during differentiation, we next tested
whether CHD1 occupancy is also associated with CHD1-
dependent gene expression. Consistent with this notion,
but in contrast with the enhancer-specific function of
BRD4 (35), CHD1-dependent genes in both osteoblast and
adipocyte-differentiated MSC as well as in hFOB 1.19 dis-
played significantly higher CHD1 occupancy near the TSS
compared to down- or unregulated genes (Figure 3A, B). In
hFOB 1.19, we next classified the CHD1-regulated genes
into high and low CHD1-occupied fractions (Supplemen-
tary Figure S4G) according to the previously introduced
threshold value (Supplementary Figure S4E). As expected,
the low occupied fraction of CHD1-dependent genes was
significantly less expressed compared to the highly occu-
pied fraction (Supplementary Figure S4G), which was en-
riched in GO terms associated with skeletal system and de-
velopmental processes (Figure 3C). This was not the case
for the low CHD1-occupied fraction (Supplementary Ta-
ble S4). The dependency on CHD1 was further verified by
qRT-PCR for genes from the high CHD1 fraction (Figure
3D, Supplementary Figure S5A). Notably, some of these
candidate genes were previously shown to be highly predic-
tive for ectopic bone formation (ELN, BMP4, COL11A1)
(55,56). Moreover, consistent with a general importance
for CHD1 in controlling osteoblast-specific transcriptional
changes, we observed an induction of CHD1-dependent
genes during osteoblast differentiation in both hFOB 1.19
and MSC (Figure 3E), which could be also verified for in-
dividual genes (Figure 3F and H). In contrast, genes upreg-
ulated after CHD1 depletion were mainly downregulated
during differentiation and unregulated genes remained un-
changed during differentiation. Altogether, these data in-
dicate that osteoblast-specific genes highly occupied by
CHD1 are more dependent on CHD1 function, supporting
a direct function for CHD1 in the transcriptional regulation
of these genes.
Given the pivotal role of transcription factors (TFs) in
the regulation of gene expression we sought to analyze if
CHD1-regulated genes may utilize a particular repertoire
of TF during osteoblast cell fate commitment. Interestingly,
none of the known TFs involved in osteoblast lineage com-
mitment displayed a particular enrichment at the promoter
regions of CHD1-dependent genes (Supplementary Figure
S6A and S6B). This is not surprising given the fact that
many lineage-specific TFs appear to function by binding to
distal regulatory regions, rather than promoter-proximal re-
gions. Consistent with general chromatin-associated events
associated with transcriptional regulation, epigenetic reg-
ulators such as RBBP5, SIN3A, HDAC1 and EZH2 were
among the factorsmost significantly enriched at the CHD1-
occupied promoters. As expected, CHD1 was among the
top hits as well. However, no particular differences in en-
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Figure 3. CHD1-dependent genes are enriched for CHD1 occupancy near the TSS and are induced during differentiation. (A) Cumulative percentage plots
represent CHD1 binding at CHD1-dependent (blue), -independent (green) or -upregulated (red) genes in osteoblast-differentiated MSC (MSC-Ob) and
hFOB 1.19 after siRNA-mediated CHD1 depletion. Normalized log2 formatted occupancy values of CHD1 are plotted against the cumulative percentage.
Significantly regulated (adjustedP-value< 0.05) genes were selected by a cutoff above or below±0.5 log2-fold changes upon CHD1 depletion. (B) Boxplots
of CHD1 occupancy at CHD1-regulated genes in osteoblast- (MSC-Ob) and adipocyte-differentiated (MSC-Adi) MSC as well as osteoblast-differentiated
hFOB 1.19. P-values are shown above compared groups. (C) Gene Ontology (GO) terms of CHD1-dependent genes in hFOB 1.19 identified as in A.
The two most enriched annotation clusters are listed with the adjusted P-value (Benjamini) and the count of genes within respective GO terms. (D) qRT-
PCR gene expression analysis of CHD1-dependent genes enriched in the GO-terms shown in C in differentiated hFOB 1.19 (BMP4, APCDD1, AXIN2,
SORT1, CTGF, COL11A1). The gene expression was calculated relative to the undifferentiated control samples and normalized to the housekeeping gene
RPLP0. Values are mean ± SD (n = 3). (E) Differentiation-induced gene expression changes in MSC and hFOB 1.19 of CHD1-regulated gene groups as
shown in A. The fold changes in gene expression are log2 transformed (log2FC) and represented by boxplots. (F) Genomic occupancy profiles of CHD1
and H3K27ac as well as mRNA expression profiles in undifferentiated (green) and osteoblast-differentiated conditions (red) at the differentiation-induced
and CHD1-dependent genes SIX1 and DUSP1. ChIP- and RNA-seq values are normalized to RPGC and RPKM, respectively. The black arrow denotes
the TSS and indicates the direction of transcription. (H) qRT-PCR analysis in MSC-Ob for DUSP1 and SIX1 in undifferentiated control (Undiff.) and
osteoblast-differentiated conditions (Ob. diff.). Values are shown relative to the Undiff. control condition and are normalized to 18S rRNA. Mean ± SD
(n = 3).
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richment of potential factors were observed between the
CHD1-dependent and CHD1-unregulated promoters, sug-
gesting a complex interplay between distal lineage-specific
enhancer regions and TSS-proximal CHD1 function dur-
ing differentiation.
CHD1 regulates early RNAPII elongation and promotes
H2A.Z occupancy around the TSS
To further investigate the mechanisms by which CHD1
controls differentiation-induced gene expression, we ana-
lyzed the chromatin landscape around the TSS of CHD1-
dependent and highly occupied genes (Figure 3A) by ex-
amining chromatin accessibility (DNase I hypersensitiv-
ity) as well as the occupancy of the histone modifica-
tionsH3K27ac,H2Bub1, andRNAPII andBromodomain-
containing protein 4 (BRD4) in hFOB 1.19. BRD4 is a cen-
tral regulator of lineage- and tumor-specific transcriptional
progams and functions to increase transcriptional activity
by binding to acetylated lysine residues at distal and proxi-
mal regulatory regions (30,34,35). CHD1-dependent genes
showed a high occupancy of CHD1 which extended into
the gene body, while displaying comparatively low RNAPII
occupancy around the TSS (Figure 4A). Concordant with
lowerRNAPII levels, we also detected lowerDNase I hyper-
sensitivity but higher enrichment of BRD4 andH3K27ac at
these sites (Figure 4A). Interestingly, during differentiation
these regions displayed increased RNAPII occupancy as
well as DNase I hypersensitivity, suggesting increased chro-
matin remodeling is associated with osteoblast-specific gene
induction (Figure 4B). We next tested whether CHD1 is re-
quired for chromatin accessibility at the TSS of the depen-
dent genes using Formaldehyde-Assisted Identification of
Regulatory Elements (FAIRE) analyses. However, CHD1
depletion did not significantly affect chromatin accessibility
at several CHD1-dependent osteoblast-specific genes (Sup-
plemental Figure S7A). We further analyzed the underlying
DNA sequence of CHD1-dependent genes by a nucleosome
positioning prediction tool (57) and observed a higher prob-
ability of nucleosome occupancy downstream of the TSS of
CHD1-dependent genes compared to repressed or unregu-
lated genes (Supplementary Figure S7B). Thus, it is possi-
ble that the higher signals observed for CHD1, BRD4 and
H3K27ac downstream of the TSS at these genes may be as-
sociated with more stably positioned nucleosomes.
Since CHD1 was shown to increase nucleosome turnover
immediately downstream of the TSS and subsequently sup-
port early elongation of RNAPII into the gene body (GB)
(16,24), we analyzed the differential occupancy of RNAPII
near the TSS and across the GB by using the previously
described ‘pausing ratio’ estimation (51,52) as a proxy for
release from promoter proximal pausing. Therefore, the
‘pausing ratio’ was defined as previously described (51,52)
by dividing the occupancy of RNAPII near the TSS of
each gene by its occupancy across the GB of the same
gene. Furthermore, H2B monoubiquitination (H2Bub1), a
histone modification previously described to be regulated
by CHD1 (29) and positively correlated with the elongat-
ing RNAPII was measured as an additional read-out for
transcriptional elongation (58). Similar to the changes in
mRNA expression upon CHD1 depletion and consistent
with decreased RNAPII elongation, we observed a decrease
inH2Bub1 occupancy on the transcribed regions of CHD1-
dependent, an increase at repressed genes, and no change at
unregulated genes (Figure 4C). Consistently, RNAPII occu-
pancy decreased at the GB of CHD1-dependent genes after
CHD1 depletion, while unchanged near the TSS (Figure 4C
and D), further supporting a specific role for CHD1 in the
transition of RNAPII from initiation or early elongation
into productive elongation during differentiation. Remark-
ably, we observed a global increase of RNAPII pausing af-
ter CHD1 depletion (Figure 4E), which was most promi-
nent at unregulated and repressed genes due to a strong
increase of RNAPII at the TSS-region, with less changes
across the GB (Figure 4D). Despite this global increase of
RNAPII pausing, no global effect on gene expression was
detected, indicating differential regulatory mechanisms at
highly CHD1-occupied, CHD1-dependent genes, which are
mainly induced during differentiation, compared to CHD1-
independent genes and genes upregulated in response to
CHD1 depletion.
Previous studies showed that H2A.Z occupancy near the
TSS decreases RNAPII pausing inDrosophila (18) through
the formation of low salt-sensitive and instable nucleosomes
together with H3.3, which may decrease the nucleosomal
barrier for RNAPII (59,60). To further analyze the ob-
served effects on RNAPII pausing and the regulation of
CHD1-dependent genes in respect to H2A.Z and H3.3, we
performed ChIP-seq for these histone variants after CHD1
depletion. Interestingly, whereas no significant change was
observed in H3.3 occupancy, H2A.Z levels uniformly de-
creased near the TSS of all genes following CHD1 deple-
tion (Supplementary Figures S7C and S8A). Notably, the
reduction in H2A.Z occupancy was not due to altered pro-
tein levels (Supplementary Figure S7D). Furthermore, we
tested whether lower H2A.Z levels were caused by a gen-
eral decrease in H2A occupancy. However, H2A levels re-
mained unaltered at the genes which displayed a reduc-
tion in H2A.Z occupancy following CHD1 knockdown
(Supplementary Figure S8A), possibly suggesting a role for
CHD1 in the formation of heterotypic nucleosomes con-
taining canonical H2A and H2AZ. Since H2A.Z and H3.3
are also associated with enhancers (61,62), we analyzed the
occupancy of the indicated histone variants at these sites
as well (Supplementary Figure S8B). Surprisingly, whereas
H2A.Z levels slightly increased at BRD4-bound osteoblast
specific enhancers, H3.3 occupancy decreased substantially.
Interestingly, RNAPII remained unaffected at these en-
hancer sites with CHD1 knockdown (Supplementary Fig-
ure S8B). Altogether, these findings indicate a differential
function of CHD1 in affecting H3.3 and H2A.Z dynamics
at TSS and enhancers, where decreased H2A.Z levels near
the TSS following CHD1 depletion may result in increased
RNAPII pausing and decreased transcriptional elongation
of osteoblast-specific genes.
DISCUSSION
Differentiation requires an intricate, spatially and tempo-
rally orchestrated reprogramming of transcriptionwhich di-
rects cell-fate decisions. These changes are coordinated by
transcription factor binding at proximal and distal regu-
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Figure 4. CHD1 is required for effective elongation of RNA Polymerase II. (A) Aggregate plots of CHD1, RNA Polymerase II (RNAPII), and DNaseI
hypersensitivity as well as BRD4 and H3K27ac around the TSS of CHD1-dependent (blue), -repressed (red) and -unregulated (green) gene groups in
hFOB 1.19. (B) DNaseI hypersensitivity and RNAPII occupancy are shown for CHD1-dependent genes in undifferentiated (grey) and differentiated (blue)
conditions around the TSS in hFOB 1.19. (C) RNAPII and H2Bub1 aggregate plots over averaged CHD1-regulated gene groups (as in A) in hFOB 1.19
transfected with control (siCon) or CHD1 (siCHD1) siRNAs. (D) Quantification of RNAPII occupancy near the TSS, gene body (GB) and ratio of TSS
and GB for CHD1-regulated gene groups (as in A) in hFOB 1.19 transfected with siCHD1 or siCon. P-values are shown above the respective comparison
groups. (E) The pausing ratio of RNAPII in control (siCon) and CHD1-depleted (siCHD1) hFOB 1.19 is represented via a cumulative percentage plot. The
quantification is shown in the boxplot on the right. Pausing ratios are shown as log2 transformed values. The P-values between the groups are indicated.
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latory elements which promotes the recruitment of cofac-
tors and the general transcriptionmachinery, resulting in al-
tered chromatin states and initiation of gene activity. Thus,
chromatin remodeling, histonemodification and histone ex-
change are central mechanisms in gene transcription, where
they promote gene expression, in part, by enabling RNAPII
elongation.
Although CHD1 is an intensively investigated chromatin
remodeler, its genome-wide occupancy and importance for
transcriptional regulation during differentiation had not
been addressed in-depth to date. In this study, we uncover
a previously unknown function of CHD1 in osteoblast dif-
ferentiation. Importantly, we show a preferential pattern of
CHD1-occupancy changes during osteoblast and adipocyte
differentiation downstream of the TSS on differentiation-
induced genes, where CHD1-dependence is tightly coupled
to its occupancy. Consistent with our observations in hu-
man cells, an importance of CHD1 downstream of the TSS
in facilitating productive elongation of RNAPII into the
gene body by promoting nucleosome turnover and remodel-
ing of the nucleosomal barrier was previously demonstrated
in mouse embryonic fibroblasts (16).
Since a large fraction of CHD1-dependent genes in
the investigated systems were induced during differentia-
tion, CHD1 occupancy downstream of the TSS appears
to play a particularly important role in the activation of
differentiation-specific genes, while not necessarily being re-
quired for the expression of lineage-independent genes. This
view is consistent with previous studies which revealed a
requirement of CHD1 in spatiotemporal gene regulation,
where it was required for gene activation in Drosophila and
in human prostate cancer cells (20,25), as well as during
reprogramming and differentiation in mouse cells (10,27).
During gene activation, the chromatin landscape is remod-
eled from a transcriptionally silent and more condensed to
an active and open chromatin state, which involves the ex-
change of histone variants, changes in post-translational
histone modifications and increased nucleosome turnover
(14,63–65). Surprisingly, although RNAPII occupancy was
low at CHD1-dependent genes, we observed high levels of
CHD1 occupancy around and downstream of the TSS, pre-
sumably coinciding with the first nucleosome (+1 nucleo-
some), which represents a barrier to the elongatingRNAPII
(66). We speculate that, as indicated in previous studies
(16,24), increased CHD1 occupancy at these sites may be
necessary for nucleosome turnover to facilitate the transi-
tion from transcriptional initiation to productive elonga-
tion. Nucleosome turnover can also alter the chromatin
landscape by promoting the exchange of modified with un-
modified or differentially modified histones (63,67). Fur-
thermore, high CHD1 levels might be necessary to sup-
port the opening and remodeling of chromatin during gene
activation at regions containing a particular epigenetic or
chromatin signature or exhibiting a particular repertoire
of chromatin-associated factors or transcription factors. In
fact, the prominent BRD4 occupancy at these sites might
support or be a direct consequence of such an event (68,69).
Well positioned nucleosomes downstream of the +1 nucle-
osome may also represent additional barriers to RNAPII,
which require the presence of chromatin remodelers such as
CHD1 for efficient gene transcription.
In addition to and consistent with increased pausing
of RNAPII at highly occupied CHD1-dependent genes,
we observed decreased occupancy of the histone variant
H2A.Z, but not canonical H2A, downstream of the TSS
after CHD1 depletion. Interestingly, H2A.Z occupancy is
negatively correlated with the +1 nucleosome barrier (18)
and was further associated with nucleosome instability
when in complex with the histone variant H3.3 (59,60,70).
Our results support the notion that CHD1 modulates or
promotes the exchange of the histone variant H2A.Z in a
genome-wide manner near the TSS, thereby reducing nu-
cleosome stability and promoting nucleosome turnover, re-
sulting in a decreased barrier for RNAPII. Interestingly, we
could not observe an effect of CHD1-depletion on H2A.Z
occupancy at enhancer regions, pointing to another CHD1-
independent mechanism at these sites. Although studies in
Drosophila showed a CHD1-dependent incorporation of
H3.3 into chromatin (71), we were unable to detect any sig-
nificant change in H3.3 occupancy near the TSS in CHD1-
depleted cells. Concordantly, it was shown that CHD1, un-
like CHD2, had only minor effects on H3.3 turnover at sin-
gle genes in human cells (72), whereas CHD1 rather main-
tained open DNA-regions. This further supports the idea
that CHD1 contributes to establishing an active and open
chromatin state at differentiation-induced genes.
AlthoughCHD1-depletion generally impaired osteoblast
differentiation-induced gene expression, it surprisingly re-
sulted in enhanced transcription of the osteoblast marker
genes ALPL and BGLAP in MSC. This is likely unre-
lated to the effects of CHD1 near the TSS as only low
levels of CHD1 were detected at the TSS of the BGLAP
or ALPL genes (data not shown). Interestingly, this in-
hibitory effect of CHD1 can be potentially explained by
the recently discovered interaction of CHD1 with LSD1
(73), which was shown to repress osteoblast differentiation
by silencing ALPL and BGLAP expression (74). In con-
trast to the higher expression of these early osteoblastic
markers, CHD1 depletion led to impaired mineralization
and decreased expression of extracellular matrix-associated
genes. Interestingly, symptoms associated with osteomala-
cia also include high alkaline phosphatase levels accom-
panied by decreased bone mineralization. Although this
disease is mainly described to be caused by malnutrition,
heredity has also been implicated in osteomalacia (75,76).
Thus, it is tempting to speculate whether mutation or al-
tered expression of CHD1 in some patients could lead to
osteomalacia.
Altogether, our results provide further mechanistic in-
sight into the function of CHD1 during differentiation by
analyzing its genome-wide occupancy and effects on gene
expression. Remarkably, the significance of CHD1 for os-
teoblast biology is further supported by in vivo ectopic bone
formation studies in mice. Furthermore, we provide evi-
dence that CHD1 is required for efficient transcriptional
regulation during lineage specification. Further studies will
be required to determine the role of CHD1 in the con-
text of different lineage-specifying transcription factors and
transcriptional coregulatory complexes like Mediator. We
hypothesize that the absence or decreased expression of
CHD1, for example in prostate cancer where CHD1 is fre-
quentlymutated or deleted (77), may result in aberrant tran-
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scriptional changes which may affect therapeutic respon-
siveness. Analogous to the synthetic lethal effects we re-
cently reported in response to PARP inhibitor treatment
of CHD1-deficient cells following DNA damage (78), we
speculate that the application of molecules such as BET
inhibitors to CHD1-deficient cells may further increase
RNAPII pausing and specifically target this subset of tu-
mors. Together, these findings reveal an important role for
CHD1 in lineage specification and provide a foundation
for further analyses examining its function in various bone-
related diseases as well as its tumor suppressor function and
the targetability of CHD1-deficient tumors.
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